No results for ‘’
Metropolis Healthcare Ltd
₹567.95
(1.41%)
Fri, 10 Jul 2026, 00:19 pm
Health Services
Medical/Nursing Services
24.5KMetropolis Healthcare EV/EBITDA Ratio
| Particulars | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 50.95 | 62.62 | 48.89 | 44.90 | 69.42 | 55.50 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 | 0 | 12.44 | 16.21 | 11.76 | 6.47 | 8.07 | 6.08 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | 0 | 7.58 | 11.49 | 8.52 | 5.59 | 7.35 | 6.04 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 0 | 29.67 | 44.19 | 40.84 | 26.42 | 33.82 | 30.45 |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | 0 | 6332Cr | 11151Cr | 10671Cr | 6578Cr | 8949Cr | 8136Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 | 0 | 29.13 | 37.47 | 29.73 | 21.70 | 29.83 | 25.92 |
| Debt to equity ratio | 0.07 | 0.04 | 0.02 | 0 | 0 | 0.04 | 0.13 | 0.16 | 0.43 | 0.27 | 0.18 | 0.15 |
| Return on equity % | 0 | 18.36 | 23.98 | 33.78 | 28.25 | 28.84 | 27.03 | 29.77 | 26.89 | 15.25 | 12.26 | 11.95 |
Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio
The Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Metropolis Healthcare Ltd's valuation, profitability, and overall financial performance. Tracking the Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Metropolis Healthcare Ltd (NSE: METROPOLIS, BSE: 542650) is currently trading at ₹567.95, with a market capitalization of ₹11612.66Cr. As a leading company in the Health services sector and Medical/Nursing services industry, monitoring the Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio Current Value
The current Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio stands at 25.92.
The Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 25.92
- 2023: 29.83
- 2022: 21.70
- 2021: 29.73
- 2020: 37.47
The decline in Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Metropolis Healthcare Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.